Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10248 |
Adenosine antagonist-1
|
Adenosine Receptor | GPCR/G Protein; Neuroscience |
Adenosine antagonist-1 可作为一种腺苷 A3 受体 (AA3R) 拮抗剂。 | |||
T40307 |
Adenosine receptor antagonist 1
|
||
Adenosine receptor antagonist 1 is a highly selective antagonist for the A2aR adenosine receptor, exhibiting an IC50 value of 0.29 nM. It demonstrates a remarkable 14-fold selectivity towards the A2aR receptor in comparison to the A2bR receptor. | |||
T37792 |
A2A receptor antagonist 1
CPI-444 analog,A2A receptor antagonist 1 |
Adenosine Receptor | GPCR/G Protein; Neuroscience |
A2A receptor antagonist 1 (CPI-444 analog)是腺苷 A2A 和 A1受体的拮抗剂,Ki 值分别为4和264 nM。 | |||
T10058 |
A2B receptor antagonist 1
|
Adenosine Receptor | GPCR/G Protein; Neuroscience |
A2B receptor antagonist 1 是一个有效的 A2B 腺苷受体 (A2B adenosine receptor) 拮抗剂。 | |||
T14078 |
AB928
|
Adenosine Receptor | GPCR/G Protein; Neuroscience |
AB928 是可口服的选择性腺苷受体(A2aR/A2bR)双拮抗剂,可减轻腺苷介导的免疫抑制,具有免疫调节和抗肿瘤活性。 | |||
T8312 |
Derenofylline
|
Adenosine Receptor | GPCR/G Protein; Neuroscience |
Derenofylline 是一个有选择性的、具有口服活性的腺苷A1受体的拮抗剂,可抑制心肌纤维化,降低蛋白尿,对腺苷A1、A3和A2A 受体的Ki 值分别为 1、200 和 398 nM。 | |||
T15418 |
GS-6201
CVT-6883 |
Adenosine Receptor | GPCR/G Protein; Neuroscience |
GS-6201 (CVT-6883) 是选择性腺苷 A2B 受体拮抗剂。它对人腺苷 A2B 受体具有高亲和力和选择性 (Ki=22 nM)。它降低了小鼠急性心肌梗死后心脏中 caspase-1 的活性,并减弱了心脏重塑。它减弱了致敏小鼠 NECA,AMP 或变应原诱导的气道反应性。 | |||
T22031 |
ANR 94
|
Adenosine Receptor | GPCR/G Protein; Neuroscience |
ANR94 是一种有效的、选择性的腺苷 A2A 受体 (AA2AR) 拮抗剂,对 hAA2AR 的Ki 值为 46 nM。ANR94 具有用于帕金森病的研究潜力。 | |||
T70996 |
FK-838
|
||
FK-838 is an adenosine subtype-1 receptor antagonist. | |||
T72000 |
N 0840
|
||
N 0840 is a selective, orally active A(1) adenosine receptor antagonist. | |||
T60872 | Adenosine receptor antagonist 3 | ||
Adenosine receptor antagonist 3 具有用于癌症疾病研究的潜力,它是腺苷受体的有效拮抗剂。 | |||
T24384 |
L-97-1
L97-1,L 97-1 |
||
L-97-1 is an antagonist of the adenosine A1 receptor. | |||
T70648 |
FK-352
|
||
FK-352 is a pyrazolopyridine derivative and adenosine-1 receptor antagonist. | |||
T62611 |
Adenosine receptor antagonist 2
|
||
Adenosine receptor antagonist 2 是一种具有口服活性的 A2a (IC50: 1 nM) /A2b (IC50: 3 nM) 腺苷受体拮抗剂。Adenosine receptor antagonist 2 表现出抗肿瘤效果。 | |||
T60580 |
A1AR antagonist 2
|
||
A1AR antagonist 2 (compound 18h) 是 A1腺苷受体 (A1 adenosine receptor) 的有效的选择性拮抗剂。A1AR antagonist 2对于 hA1, hA2A,hA2B 的Ki 值分别为 1.49、10.2 和 50.1 nM。 | |||
T61850 |
Adenosine receptor inhibitor 1
|
||
Adenosine receptor inhibitor 1 is a highly potent and selective antagonist of adenosine receptor (AR). It exhibits exceptional affinity for A1 AR, A2A AR, A2B AR, and A3 AR, with respective Ki values of >1000, 68.5, >1000, >1000 nM. This compound demonstrates notable antinociceptive, anti-inflammatory, and peripheral analgesic properties. Therefore, Adenosine receptor inhibitor 1 holds great promise for investigating cancer and neurodegenerative diseases [1]. | |||
T60687 | A1AR antagonist 1 | ||
A1AR antagonist 1 (compound 18g) 是A1腺苷受体的选择性拮抗剂。A1AR antagonist 1对 hA1, hA2A,hA2B 受体的Ki 值分别为 2.08、6.91 和 31.2 nM。 | |||
T62134 | A1/A3 AR antagonist 1 | ||
A1/A3 AR antagonist 1 (compound 10) 是一种有效的、双重腺苷酸 1 (A1)和腺苷酸 3 (A3)受体拮抗剂,能够作用于人 A1 (Ki: 37.6 nM)、人 A3 (Ki: 25.4 nM) 和大鼠 A1 (Ki: 1.47 nM)。A1/A3 AR antagonist 1 能够用于研究肾衰竭、炎症性肺部疾病和阿尔茨海默症。 | |||
T60591 |
A2AAR antagonist 1
|
||
A2AAR antagonist 1 (compound 21a) 是A2AAR(腺苷A2A 受体) 的拮抗剂,具有高配体效率,Ki 值为 20 nM。A2AAR antagonist 1 可用于神经退行性疾病的相关研究。 | |||
T60615 |
A1AR antagonist 6
|
||
A1AR antagonist 6 (化合物 15) 是 A1 腺苷受体(A1AR)的有效的选择性拮抗剂,其pKi 值为 7.13,pIC50值为 6.38。 | |||
T60915 |
A1AR antagonist 5
|
||
A1AR antagonist 5 (化合物 20) 是A1 腺苷受体(A1AR)的有效选择性拮抗剂,其pKi 值为 6.11,pIC50值为 5.83。 | |||
T61536 |
A1AR antagonist 4
|
||
A1AR antagonist 4 (compound 22) is a highly developed chemical compound that acts as a potent and selective antagonist of the A1 adenosine receptor (A1AR). It possesses a pIC50 value of 5.51 and a pKi value of 6.29 [1]. | |||
T74606 | A2A/A3 AR antagonist-1 | ||
A2A/A3 AR antagonist-1 (化合物 23) 是一种双重 A2A/A3adenosine receptor(AR)荧光配体,对 hA2AAR 和 hA3AR 的 Ki 值分别为 90 nM 和 31.8 nM。 | |||
T26855 |
BMS-665053
BMS665053 |
||
BMS-665053 is a corticotropin-releasing factor-1 (CRF1) receptor antagonist (IC50 = 1.0 nM). BMS-665053)11 is a potent inhibitor of CRF-stimulated cyclic adenosine monophosphate (cAMP) production in human Y-79 retinoblastoma cells (IC50 = 4.9 nM). In addi | |||
T72626 |
A2AR-antagonist-1
|
Adenosine Receptor | GPCR/G Protein; Neuroscience |
A2AR-antagonist-1 (compound 38) 为一种口服活性的腺苷 A2A 受体 (A2AR) 拮抗剂,IC50 值为 29 nM。此化合物展示出抗肿瘤作用,并在小鼠肝微粒体中表现出良好的代谢稳定性,半衰期为 86.1 分钟。同时,A2AR-antagonist-1 能够作为 T 细胞激活剂,通过抑制免疫抑制分子 LAG-3 和 TIM-3,以及增强 GZMB、IFNG 和 IL-2 等效应分子的表达。 | |||
T37014 | Inupadenant | ||
Inupadenant is an orally active, highly selective A2A receptor antagonist. Inupadenant is not brain-penetrant. Inupadenant has potent anti-tumor activity[1]. [1]. Laurence Buisseret, et al. Phase 1 trial of the adenosine A2Areceptor antagonist inupadenant (EOS-850): Update on tolerability, and antitumor activity potentially associated with the expression of the A2A receptor within the tumor. Journal of Clinical Oncology. Volume 39, Issue 15_suppl. | |||
T70770 |
Cyclazosin Free Base
|
||
Cyclazosin Free Base is a monocarboxylic acid amide obtained by formal condensation of the carboxy group of furoic acid with the secondary amino group of 6,7-dimethoxy-2-[(4aR,8aS)-octahydroquinoxalin-1-yl]quinazolin-4-amine. It has a role as an adenosine A2A receptor antagonist. It is a member of quinazolines, a member of furans, an aromatic ether, a quinoxaline derivative, an aromatic amide and a monocarboxylic acid amide. | |||
T63400 |
hA2A/hCA XII modulator 1
|
||
hA2A/hCA XII modulator 1 是 hA2A 腺苷受体 (hA2AAR) 的有效拮抗剂,是一种三唑并吡嗪, 能够作用于hA2AAR (Ki: 6.4 nM)、hA1AR (Ki: 4.819 μM)、hA3AR (Ki>30 μM)。hA2A/hCA XII modulator 1 也人碳酸酐酶 XII (hCA XII) 的有效抑制剂,能够作用于 hCA XII (Ki: 6.2 nM)、hCA II (Ki: 46 nM)、hCA IX (Ki: 466 nM) 和 hCA I (Ki: 8.351 μM)。hA2A/hCA XII modulator 1 表现出研究癌症的潜力。 | |||
T60511 |
Theophylline sodium glycinate
|
||
Theophylline (1,3-Dimethylxanthine) sodium glycinate 是一种有效的磷酸二酯酶 (PDE) 抑制剂,可抑制 PDE3 活性以松弛气道平滑肌。Theophylline sodium glycinate 可用于研究哮喘和慢性阻塞性肺疾病 (COPD) 。Theophylline sodium glycinate 也是一种腺苷受体拮抗剂和组蛋白脱乙酰酶 (HDAC) 激活剂。 Theophylline sodium glycinate 通过增加 IL-10 和抑制 NF-κB 的核输入而具有抗炎活性。Theophyllin sodium glycinate 可诱导细胞凋亡。 | |||
T36679 |
Rp-cAMPS sodium salt
|
||
Rp-cAMPS sodium salt, a cAMP analog, is a potent, competitive cAMP-induced activation of cAMP-dependent PKA I and II (Kis of 12.5 μM and 4.5 μM, respectively) antagonist. Rp-cAMPS sodium salt is resistant to hydrolysis by phosphodiesterases[1][2][3][4][5][6]. A membrane-permeable competitive cAMP antagonist (Rp-cAMPS) that blocks PKA activation by binding to the regulatory subunits without dissociating the kinase holoenzyme also inhibits synaptic plasticity but has no effect on normal synaptic t... |